Eikonizo Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Eikonizo Therapeutics?

Eikonizo Therapeutics has 2 investors including National Institute of Neurological Disorders and Stroke And Novo Nordisk.

Q: How much funding has Eikonizo Therapeutics raised to date?

Eikonizo Therapeutics has raised obfuscated.

Overview

Eikonizo Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Eikonizo Therapeutics

CB Rank

67551

Eikonizo Therapeutics is a biopharmaceutical company.

Founded

obfuscation

Private

Grant

Cambridge, Massachusetts, United States

1-10

www.eikonizo.com/

Biotechnology

Health Care

Pharmaceutical

Funding Rounds

Grant

OBF

obfuscation

Corporate Round

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Frederick Schroeder: Co-Founder and Director
Rick Lundberg: President & CEO

Details

Legal Name

Eikonizo Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Frederick Schroeder, Jacob Hooker, Janice Kranz, William (Bill) Shaw

About the Company

Eikonizo is developing life-changing treatments by producing brain-penetrant small compounds and utilizing in vivo target engagement approaches to speed therapeutic discovery.

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Insight

See this Growth Insight

Eikonizo Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

EKZ-102

An oral, brain-penetrant, selective small molecule HDAC6 inhibitor designed to modify disease progression in neurodegenerative disorders such as ALS and Alzheimer’s disease.

Peripheral HDAC6 Inhibitors

Selective small molecule HDAC6 inhibitors designed to act outside the central nervous system for treatment of cardiorenal and related diseases.

Research & Development

Eikonizo Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Eikonizo Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Eikonizo Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Eikonizo Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Eikonizo Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Eikonizo Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Eikonizo Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Eikonizo Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Eikonizo Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Eikonizo Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Eikonizo Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
National Institute of Neurological Disorders and Stroke	Yes	Grant - Eikonizo Therapeutics	—
National Institute of Neurological Disorders and Stroke	Yes	Grant - Eikonizo Therapeutics	—
National Institute of Neurological Disorders and Stroke	Yes	Grant - Eikonizo Therapeutics	—
National Institute of Neurological Disorders and Stroke	Yes	Grant - Eikonizo Therapeutics	—
National Institute of Neurological Disorders and Stroke	Yes	Grant - Eikonizo Therapeutics	—